August 6, 2025 — Seer, Inc. (Nasdaq: SEER) reported its second-quarter financial results, revealing a 32% year-over-year revenue increase. Revenue reached $4.1 million, driven by higher product sales and service revenue. The company launched the high-throughput Proteograph® ONE assay and SP200 automation instrument during the quarter.
Key highlights include the launch of the new high-throughput Proteograph ONE assay and SP200 automation instrument, which enable increased scale and efficiency. Additionally, Seer announced a collaboration with Korea University for a 20,000-sample population-scale proteomics study using the Proteograph ONE assay to develop AI-driven diagnostics for cancers in young adults.
Omid Farokhzad, Chair and CEO of Seer, noted that the launches significantly enhance the platform’s scalability and efficiency. He expressed pride in the team’s focus on innovation and execution, despite macroeconomic pressures.
The company’s cash, cash equivalents, and investments totaled approximately $263.3 million as of June 30, 2025. Seer anticipates full-year 2025 revenue to range from $17 million to $18 million, marking a 24% growth at the midpoint over 2024.
Revenue for the second quarter of 2025 was $4.1 million, up from $3.1 million in the same period last year. Product revenue was $2.7 million, including sales of Proteograph instruments and consumable kits. Service revenue reached $1.2 million, including $409,000 from related parties, primarily related to Seer Technology Access Center service projects. Gross profit was $2.1 million, with a gross margin of 52%.
Operating expenses were $22.6 million, a 21% decrease compared to $28.8 million in the prior year period. The net loss for the quarter was $19.4 million, compared to $22.9 million for the corresponding prior year period.
Seer sets the standard in deep, unbiased proteomics, integrating proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced software.
Investor Contact: Carrie Mendivil, investor@seer.bio
Media Contact: Patrick Schmidt, pr@seer.bio
Source: Seer, Inc.
